LogicBio Therapeutics
(NASDAQ:LOGC)
LogicBio Therapeutics, Inc. - Common Stock is expected to split Monday, August 15, 2022 with a ratio of 1:5
LogicBio Therapeutics, Inc. - Common Stock recently split on Friday, August 12, 2022 with a ratio of 1:3
$0.6199
-0.0545[-8.08%]
At close: Aug 12
$0.605
-0.0149[-2.40%]
After Hours: 6:40PM EDT
Day High/Low0.6 - 0.69
52 Week High/Low0.34 - 2.54
Open / Close0.68 / 0.62
Float / Outstanding23.4M / 33M
Vol / Avg.298.1K / 232.2K
Mkt Cap20.4M
P/E-
50d Avg. Price0.44
Div / Yield-
Payout Ratio-
EPS-0.28
Total Float23.4M

LogicBio Therapeutics (NASDAQ:LOGC), Quotes and News Summary

LogicBio Therapeutics (NASDAQ: LOGC)

Day High/Low0.6 - 0.69
52 Week High/Low0.34 - 2.54
Open / Close0.68 / 0.62
Float / Outstanding23.4M / 33M
Vol / Avg.298.1K / 232.2K
Mkt Cap20.4M
P/E-
50d Avg. Price0.44
Div / Yield-
Payout Ratio-
EPS-0.28
Total Float23.4M
Sector: Health Care.Industry: Biotechnology
LogicBio Therapeutics Inc is a genome editing company focused on developing medicines to durably treat rare diseases in patients with significant unmet medical need using GeneRide, its proprietary technology platform. Its product candidates include LB-001, LB-101, LB-201 and LB 301.

Earnings

see more
FY 2023Est.ActualSurprise
EPS
(EXPECTED)2023-12-20
REV
FY 2023Est.ActualSurprise
EPS
(EXPECTED)2023-11-09
REV

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

LogicBio Therapeutics Questions & Answers

Q
How do I buy LogicBio Therapeutics (LOGC) stock?
A

You can purchase shares of LogicBio Therapeutics (NASDAQ: LOGC) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are LogicBio Therapeutics's (LOGC) competitors?
Q
What is the target price for LogicBio Therapeutics (LOGC) stock?
A

The latest price target for LogicBio Therapeutics (NASDAQ: LOGC) was reported by Cantor Fitzgerald on Friday, August 12, 2022. The analyst firm set a price target for 4.00 expecting LOGC to rise to within 12 months (a possible 545.27% upside). 50 analyst firms have reported ratings in the last year.

Q
Current Stock Price for LogicBio Therapeutics (LOGC)?
A

The stock price for LogicBio Therapeutics (NASDAQ: LOGC) is $0.6199 last updated August 12, 2022, 8:00 PM UTC.

Q
Does LogicBio Therapeutics (LOGC) pay a dividend?
A

The next LogicBio Therapeutics (LOGC) dividend date is projected to be Thursday, September 1, 2022.

Q
When is LogicBio Therapeutics (NASDAQ:LOGC) reporting earnings?
A

LogicBio Therapeutics’s FY earnings are confirmed for Wednesday, December 20, 2023.

Q
Is LogicBio Therapeutics (LOGC) going to split?
A

There is no upcoming split for LogicBio Therapeutics.

Q
What sector and industry does LogicBio Therapeutics (LOGC) operate in?
A

LogicBio Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.